Sinopharm Group Co. Ltd (X2S) — Free Cash Flow Generation Index
Sinopharm Group Co. Ltd (X2S) has a Free Cash Flow Generation Index of 0.98x as of December 2022. Free cash flow of €51.45 Billion represents 1% of operating cash flow (€52.39 Billion). Read X2S total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sinopharm Group Co. Ltd Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for Sinopharm Group Co. Ltd across 13 annual periods. Explore how much does Sinopharm Group Co. Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Sinopharm Group Co. Ltd (2013–2025)
Year-by-year Free Cash Flow Generation Index for Sinopharm Group Co. Ltd. For the full company profile including market capitalisation, see Sinopharm Group Co. Ltd stock valuation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.89x | €12.52 Billion | €14.14 Billion | €1.62 Billion | ▲ +6.8% |
| 2024 | 0.83x | €9.58 Billion | €11.55 Billion | €1.97 Billion | ▼ -4.0% |
| 2023 | 0.86x | €14.84 Billion | €17.17 Billion | €2.34 Billion | ▼ -2.3% |
| 2022 | 0.88x | €18.55 Billion | €20.96 Billion | €2.13 Billion | ▼ -11.5% |
| 2021 | 1.00x | €9.31 Billion | €9.31 Billion | €2.07 Billion | ▲ +0.0% |
| 2020 | 1.00x | €11.15 Billion | €11.15 Billion | €1.90 Billion | ▲ +15.7% |
| 2019 | 0.86x | €16.23 Billion | €18.78 Billion | €2.21 Billion | ▲ +1165.0% |
| 2018 | 0.07x | €249.62 Million | €3.65 Billion | €3.24 Billion | ▲ +196.4% |
| 2017 | -0.07x | €-227.35 Million | €3.21 Billion | €2.12 Billion | ▼ -106.2% |
| 2016 | 1.15x | €10.62 Billion | €9.26 Billion | €1.36 Billion | ▲ +6.6% |
| 2015 | 1.08x | €14.43 Billion | €13.41 Billion | €1.02 Billion | ▼ -14.7% |
| 2014 | 1.26x | €7.01 Billion | €5.56 Billion | €1.45 Billion | ▲ +2.6% |
| 2013 | 1.23x | €6.07 Billion | €4.94 Billion | €1.13 Billion | — |